Cross-sectional analysis identifies high-density lipoprotein cholesterol-related biomarkers linked to COPD prevalence, suggesting new early intervention strategies.
Our comprehensive analytical approach demonstrates that MHR and NHR are promising biomarkers associated with increased COPD prevalence. The consistency of results across epidemiological, causal inference, and machine learning methods provides robust evidence for their potential clinical utility in risk stratification and guiding early intervention strategies.
No takes yet. Share an insight, caveat, or question.
Hua et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: